[Featured Stock] Diagnostic Kit Leader Seegene Soars Amid Omicron Variant Emergence
[Asia Economy Reporter Lee Seon-ae] Seegene, considered a leading company in diagnostic kits, is showing strength following the emergence of the new coronavirus variant Omicron.
On the 29th, Seegene started trading at 79,800 won and surged to 83,900 won in the early session. As of 9:25 AM, it is trading at 78,300 won, up 8.90%. This is the first time Seegene has recovered to the 80,000 won level since last July.
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Last Year, Net Profit of Securities Firms' Overseas Subsidiaries Rose from $270 Million to $450 Million
- Experts Are Already Watching Closely..."Target Stock Price 970,000 Won" Now Only the Uptrend Remains [Weekend Money]
This is interpreted as an effect of Omicron spreading globally, starting from Africa to Europe, Canada, and other regions. Omicron was first reported by South African scientists who discovered a new variant with 32 genetic mutations in the spike protein. The WHO designated Omicron as the fifth variant of concern following Alpha, Beta, Gamma, and Delta. At the same time, other diagnostic kit stocks such as LabGenomics, Sugentech, and Access Bio are also surging.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
